Register for email alerts and news feeds:
This journal | BMJ Group
rss
Archives of Disease in Childhood - Fetal and Neonatal Edition 2004;89:F5-F8; doi:10.1136/fn.89.1.F5
Copyright © 2004 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health.
Archives of Disease in Childhood Fetal and Neonatal Edition 2004;89:F5
© 2004 Archives of Disease in Childhood Fetal and Neonatal Edition

REVIEW

Can polyclonal intravenous immunoglobulin limit cytokine mediated cerebral damage and chronic lung disease in preterm infants?

P V Mohan1, W Tarnow-Mordi2, B Stenson3, P Brocklehurst4, K Haque5, V Cavendish6 and A Cust7

1 Department of Paediatrics, Baylor College of Medicine, Houston, TX 77025, USA
2 Department of Neonatology, Westmead Hospital, and Children’s Hospital at Westmead, Sydney, NSW 2145, Australia
3 The Royal infirmary of Edinburgh at Little France, Edinburgh, EH16 4SU, Scotland, UK
4 National Perinatal Epidemiology Unit, Institute of Health Services, Oxford, OX3 7LF, UK
5 Department of Child Health, Queen Mary’s Hospital for Children, Carshalton, Surrey SM5 1AA, UK
6 Department of Clinical Sciences at North Bristol (Orthopaedic Surgery), University of Bristol, Bristol BS10 5NB, UK
7 NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW 2006, Australia

Correspondence to:
Correspondence to:
Dr Mohan
Department of Paediatrics, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77025, USA; suseela12{at}hotmail.com

ABSTRACT

Recent evidence suggests that inflammatory cytokines may play an important role in cerebral and pulmonary injury, especially in preterm infants. Immunomodulatory agents may help to limit such injury by reducing inflammation. Immunoglobulin has multiple anti-inflammatory properties and can modulate the inflammatory cytokine response. New evidence is required to test the hypotheses that prophylaxis or treatment with intravenous immunoglobulin may limit such inflammatory damage.

Keywords: cytokines; immunoglobulin; immunomodulation; inflammatory injury; preterm

Abbreviations: CLD, chronic lung disease; IL, interleukin; IVIG, intravenous immunoglobulin; TNF, tumour necrosis factor


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Tarnow-Mordi, W., Isaacs, D., Smart, D. H., Stenson, B., Haque, K. (2005). Neurodevelopmental Impairment and Neonatal Infections. JAMA 293: 932-932 [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Latest from ADC

 

ADC is co-owned by the RCPCH and is the official journal of the European Academy of Paediatrics

BMJ Careers - Latest Paediatrics and Paediatric Surgery Jobs

Paediatrics and Paediatric Surgery Jobs